May 2, 2006 --'s trust fund will run out of money in 2018, two years earlier than previously expected, the program's trustees reported Monday.
The trust fund -- known as Part A -- finances hospital stays for 42 million Medicare beneficiaries. It's already operating in the red because it spends more on those services than it brings in. But the fund is now expected to be mostly depleted by 2018 unless Congress acts to lower spending or raise taxes.
The report also warns of rapidly rising costs for physician care in doctors' offices or outpatient hospital care, known as Medicare's Part B. Current Medicare law calls for 4% to 5% pay cuts for doctors over the next few years, but those cuts are expected to be negated by Congress. That could mean substantial hikes in the premiums beneficiaries pay for their care, experts warn.
Premiums are already slated to go up 11% for most beneficiaries next year. If Congress overrides the doctors' pay cuts, it will go up even more, John L. Palmer, a public trustee for Medicare and Social Security, tells WebMD.
"Part B is going to have to go up significantly next year," he says.
The report repeats warnings that both Medicare and Social Security are now financially unsustainable, mostly because of rapid growth of the nation's retired population. But rising health costs in general are adding additional pressures to Medicare and speeding up its financial troubles, the report states.
Medicare is expected to spend about $180 billion in taxpayer money, with billions more coming from premiums paid by beneficiaries themselves.
"The message of this report is urgency," Health and Human Services Secretary Michael O. Leavitt told reporters.
The White House has proposed cutting taxpayer spending on Medicare by 0.4% if Congress doesn't come up with proposals of its own to curb spending. In January, President George Bush called for a new, bipartisan commission to recommend fixes for Medicare and Social Security, though no members have yet been appointed.
Part D Costs Lower
The report also predicted lower-than-expected costs for Medicare's new prescription drug benefit, known as Part D. Bush administration officials say a slowdown in the growth of drug costs and competition among private insurance companies meant the program would cost less than they had previously planned.